Collgard Biopharmaceuticals Overview

  • Founded
  • 1996
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1M
Latest Deal Amount

Collgard Biopharmaceuticals General Information


Developer of tissue therapeutics. The company develops unique therapeutic products that affect the turnover of collagen to prevent or treat scleroderma, solid tumors, restenosis and other fibrotic disorders.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Collgard Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Mar-2011 $1M 0000 000 Completed Product Development
2. Early Stage VC 0000 0000 Completed
1. Early Stage VC (Series A) $7M $7M Completed
To view Collgard Biopharmaceuticals’s complete valuation and funding history, request access »

Collgard Biopharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Denali Ventures Venture Capital Minority 000 0000 000000 0
Medica Venture Partners Venture Capital Minority 000 0000 000000 0
To view Collgard Biopharmaceuticals’s complete investors history, request access »